Belite Bio, Inc. ADR
BLTE·07782B104·US·ADR·Healthcare - Biotechnology-13D/G
BLTE (Belite Bio, Inc. ADR) is held by 43 institutional investors as of Q2 2026. Largest holders: RTW INVESTMENTS, LP ($110.2M), MILLENNIUM MANAGEMENT LLC ($76.2M), MAVERICK CAPITAL LTD ($61M). Net institutional sentiment: Mixed.
43
Holders
(3 Elite)
$509.5M
Total Value
54% (48)
Consensus
26 buying - 22 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Sep 9, 2026 · Insiders Sep 9, 2026 · Activists May 14, 2026 · Congress none
InsiderLYLin Yu-HsinSell $535KSep 8, 2026
InsiderLYLin Yu-HsinSell $1.7MSep 8, 2026
InsiderCHChuang Hao-YuanSell $427KSep 8, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 51
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer